News
Burrill & Company Announces Close of Burrill Brazil Fund I January 18, 2012 | Press Release
Global Financial Market Turmoil Overshadows Biotech Successes in 2011 January 03, 2012 | Press Release
Burrill & Company CEO G. Steven Burrill Featured in Ernst & Young's Connect December 23, 2011 | Press Release
See all News
G. Steven Burrill
Chief Executive Officer
Roger E. Wyse
Managing Director
Greg B. Young
Managing Director
Yuko Amizaki
Business Analyst
Chen Yee Liaw
Business Analyst
The Malaysian Life Sciences Capital Fund (MLSCF) is a life sciences venture fund specializing in early stage investments in agriculture, industrial and healthcare biotechnology. Co-managed by Burrill & Company and Malaysian Technology Development Corporation Sdn Bhd (MTDC), the fund was founded in late 2006 and currently has $150 million in committed capital.
KUALA LUMPUR, MALAYSIA:
No 36-01, Level 36 Menara Dion
27, Jalan Sultan Ismail
50250, Kuala Lumpur
Phone: 011 (603) 2072-0110
Fax: 011 (603) 2072-0330
gkishore@b-c.com
To view information about The Malaysian Life Sciences Capital Fund, which is co-managed by the Malaysian Technology Development Corporation Sdn Bhd (MTDC) and Burrill & Company, please click here.

